Suitor Smith & Nephew is down 5% premarket while target NuVasive is up 16% following the news that the companies are in talks about a merger.
Date: February 18, 2019
Source: Investing.com
Weekly round up from Life Sciences Industry.
Suitor Smith & Nephew is down 5% premarket while target NuVasive is up 16% following the news that the companies are in talks about a merger.
Date: February 18, 2019
Source: Investing.com
Sign up for DistilINFO e-Newsletters.
10 Takeover Targets To Watch In 2019
Ajax Raises $100M Fund to Invest in Healthtech Startups
Apple Quietly Adds Updates to Noise App, Mobility Tracking
NGM Bio Acquired in $135M Deal by Column Group
UK Space Agency Launches Drive to Design ‘Space Age’ Hospital
Global Cord Blood Corporation Announces Receipt of Preliminary Non-Binding Proposal to Acquire the Company
Survey: Record-Breaking M&A Surge Will Continue as Dealmakers Prioritize ESG
FDA creating innovation office to speed drug developmentSorry. No data so far.
DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.
More About Us